Cargando…

A Comparative Analysis of Cardiovascular Risk in HIV Sero-positive and Sero-negative Pre-menopausal Women

BACKGROUND: HIV infection has been associated with an increased risk of cardiovascular disease (CVD), stroke, and subclinical atherosclerosis in women. HIV-positive pre-menopausal women tend to lose the cardio-protective effect of estrogen and these women should be more vigilant in reducing their ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Raza, Ambreen, Malayala, Srikrishna Varun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631966/
http://dx.doi.org/10.1093/ofid/ofx163.429
_version_ 1783269601887387648
author Raza, Ambreen
Malayala, Srikrishna Varun
author_facet Raza, Ambreen
Malayala, Srikrishna Varun
author_sort Raza, Ambreen
collection PubMed
description BACKGROUND: HIV infection has been associated with an increased risk of cardiovascular disease (CVD), stroke, and subclinical atherosclerosis in women. HIV-positive pre-menopausal women tend to lose the cardio-protective effect of estrogen and these women should be more vigilant in reducing their risk for developing CVD. Our study intends to assess the cardiovascular risk in the HIV-positive pre-menopausal women over the last 16 years (1999-2014) using a national wide sample. METHODS: This study is a cross-sectional study using the National Health and Nutrition Examination Survey (NHANES) datasets from 1999 to 2014. The 10-year Framingham risk score for developing CAD was calculated for the HIV-positive and HIV-negative pre-menopausal women. The individual risk factors contributing to CAD including blood pressure, hemoglobin A1c, c-reactive protein (CRP), smoking status, cholesterol level, family history of CVD were compared. The populations’ intent to reduce their risk (exercise, diet modification and use of medications) and their doctor’s advice to reduce the risk (counseling on diet, exercise and weight) were also analyzed. SPSS v.19 was used for analysis and p-value < 0.05 was considered significant. RESULTS: Out of the available sample of 82,091 people, 9635 women (11.7%) met the inclusion criteria (pre-menopausal women, 18 to 55 year old, no prior history of CAD, no missing data and tested for HIV). Among them, 25 women were HIV seropositive (0.25%). Though there was no significant difference in the systolic and diastolic blood pressure, HbA1c, CRP, HDL or total cholesterol (P > 0.05); the mean Framingham risk score in pre-menopausal HIV-positive women (M = 2.12, SD = 2.73) was significantly higher than the HIV-negative women (M = 0.95, SD = 1.94); P <0.01. Neither did majority of the HIV-positive women intend to decrease their cardiovascular risk nor did their health care providers advice them to do so. CONCLUSION: This study shows that the risk of developing CVD in pre-menopausal women seems to be higher from the traditional risk factors itself. While HIV is now independent risk factor for developing CVD in women, more focus should be on reducing the risk from traditional methods like smoking cessation, diet and life style modification, blood pressure, diabetes and cholesterol and management. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5631966
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56319662017-11-07 A Comparative Analysis of Cardiovascular Risk in HIV Sero-positive and Sero-negative Pre-menopausal Women Raza, Ambreen Malayala, Srikrishna Varun Open Forum Infect Dis Abstracts BACKGROUND: HIV infection has been associated with an increased risk of cardiovascular disease (CVD), stroke, and subclinical atherosclerosis in women. HIV-positive pre-menopausal women tend to lose the cardio-protective effect of estrogen and these women should be more vigilant in reducing their risk for developing CVD. Our study intends to assess the cardiovascular risk in the HIV-positive pre-menopausal women over the last 16 years (1999-2014) using a national wide sample. METHODS: This study is a cross-sectional study using the National Health and Nutrition Examination Survey (NHANES) datasets from 1999 to 2014. The 10-year Framingham risk score for developing CAD was calculated for the HIV-positive and HIV-negative pre-menopausal women. The individual risk factors contributing to CAD including blood pressure, hemoglobin A1c, c-reactive protein (CRP), smoking status, cholesterol level, family history of CVD were compared. The populations’ intent to reduce their risk (exercise, diet modification and use of medications) and their doctor’s advice to reduce the risk (counseling on diet, exercise and weight) were also analyzed. SPSS v.19 was used for analysis and p-value < 0.05 was considered significant. RESULTS: Out of the available sample of 82,091 people, 9635 women (11.7%) met the inclusion criteria (pre-menopausal women, 18 to 55 year old, no prior history of CAD, no missing data and tested for HIV). Among them, 25 women were HIV seropositive (0.25%). Though there was no significant difference in the systolic and diastolic blood pressure, HbA1c, CRP, HDL or total cholesterol (P > 0.05); the mean Framingham risk score in pre-menopausal HIV-positive women (M = 2.12, SD = 2.73) was significantly higher than the HIV-negative women (M = 0.95, SD = 1.94); P <0.01. Neither did majority of the HIV-positive women intend to decrease their cardiovascular risk nor did their health care providers advice them to do so. CONCLUSION: This study shows that the risk of developing CVD in pre-menopausal women seems to be higher from the traditional risk factors itself. While HIV is now independent risk factor for developing CVD in women, more focus should be on reducing the risk from traditional methods like smoking cessation, diet and life style modification, blood pressure, diabetes and cholesterol and management. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631966/ http://dx.doi.org/10.1093/ofid/ofx163.429 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Raza, Ambreen
Malayala, Srikrishna Varun
A Comparative Analysis of Cardiovascular Risk in HIV Sero-positive and Sero-negative Pre-menopausal Women
title A Comparative Analysis of Cardiovascular Risk in HIV Sero-positive and Sero-negative Pre-menopausal Women
title_full A Comparative Analysis of Cardiovascular Risk in HIV Sero-positive and Sero-negative Pre-menopausal Women
title_fullStr A Comparative Analysis of Cardiovascular Risk in HIV Sero-positive and Sero-negative Pre-menopausal Women
title_full_unstemmed A Comparative Analysis of Cardiovascular Risk in HIV Sero-positive and Sero-negative Pre-menopausal Women
title_short A Comparative Analysis of Cardiovascular Risk in HIV Sero-positive and Sero-negative Pre-menopausal Women
title_sort a comparative analysis of cardiovascular risk in hiv sero-positive and sero-negative pre-menopausal women
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631966/
http://dx.doi.org/10.1093/ofid/ofx163.429
work_keys_str_mv AT razaambreen acomparativeanalysisofcardiovascularriskinhivseropositiveandseronegativepremenopausalwomen
AT malayalasrikrishnavarun acomparativeanalysisofcardiovascularriskinhivseropositiveandseronegativepremenopausalwomen